Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections.

MLA

Dietz, Julia, et al. “Efficacy of Retreatment After Failed Direct-Acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections.” Clinical Gastroenterology & Hepatology, vol. 19, no. 1, Jan. 2021, p. 195. EBSCOhost, https://doi.org/10.1016/j.cgh.2019.10.051.

APA

Dietz, J., Spengler, U., Müllhaupt, B., Schulze zur Wiesch, J., Piecha, F., Mauss, S., Seegers, B., Hinrichsen, H., Antoni, C., Wietzke-Braun, P., Peiffer, K.-H., Berger, A., Matschenz, K., Buggisch, P., Backhus, J., Zizer, E., Boettler, T., Neumann-Haefelin, C., Semela, D., & Stauber, R. (2021). Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections. Clinical Gastroenterology & Hepatology, 19(1), 195. https://doi.org/10.1016/j.cgh.2019.10.051

Chicago

Dietz, Julia, Ulrich Spengler, Beat Müllhaupt, Julian Schulze zur Wiesch, Felix Piecha, Stefan Mauss, Barbara Seegers, et al. 2021. “Efficacy of Retreatment After Failed Direct-Acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections.” Clinical Gastroenterology & Hepatology 19 (1): 195. doi:10.1016/j.cgh.2019.10.051.